American Cancer Society. (2025). Breast cancer HER2 status. Cancer.org. https://www.cancer.org/cancer/types/
breast-cancer/understanding-a-breast-cancer-diagnosis/breast-cancer-her2-status.html

American Cancer Society. (2021). Breast cancer hormone receptor status. Cancer.org. https://www.cancer.org/cancer/types/
breast-cancer/understanding-a-breast-cancer-diagnosis/breast-cancer-hormone-receptor-status.html

American Cancer Society. (2023). Your breast pathology report: Breast cancer. Cancer.org. https://www.cancer.org/cancer/diagnosis-staging/tests/biopsy-and-cytology-tests/understanding-your-pathology-report/breast-pathology/breast-cancer-pathology.html

André, F., Ciruelos, E., Rubovszky, G., Campone, M., Loibl, S., Rugo, H. S., Iwata, H., Conte, P., Mayer, I. A., Kaufman, B., Yamashita, T., Lu, Y. S., Inoue, K., Takahashi, M., Pápai, Z., Longin, A. S., Mills, D., Wilke, C., Hirawat, S., Juric, D., … SOLAR-1 Study Group (2019). Alpelisib for PIK3CA-mutated, hormone receptor-positive advanced breast cancer. The New England journal of Medicine, 380(20), 1929–1940. https://doi.org/10.1056/NEJMoa1813904

Brett, J. O., Spring, L. M., Bardia, A., & Wander, S. A. (2021). ESR1 mutation as an emerging clinical biomarker in metastatic hormone receptor-positive breast cancer. Breast Cancer Research: BCR, 23(1), 85. https://doi.org/10.1186/s13058-021-01462-3

Canadian Breast Cancer Network. (2025). Workshop: Understanding your pathology report. https://cbcn.ca/en/workshop-understanding-your-pathology-report

Erber, R., & Hartmann, A. (2020). Understanding PD-L1 testing in breast cancer: A practical approach. Breast Care (Basel, Switzerland), 15(5), 481–490. https://doi.org/10.1159/000510812

Healthline. (2024). PIK3CA mutations in breast cancer: What does it mean? https://www.healthline.com/health/
metastatic-breast-cancer/pik3ca-mutation-and-breast-cancer

Living Beyond Breast Cancer. (2024). Next-generation sequencing (NGS) test. https://www.lbbc.org/about-breast-cancer/testing/biomarker/next-generation-genome-sequencing

MyPathologyReport.ca. (2023). Pathology for patients. https://www.mypathologyreport.ca/

Nolan-Pleckham, M. (2023). The Ki-67 proliferation marker test and breast cancer treatment. Verywell Health. https://www.verywellhealth.com/ki-67-tumor-marker-test-430609

Susan G. Komen. (2023). Contents of a pathology report. https://www.komen.org/breast-cancer/diagnosis/pathology-reports/contents/